<Record>
<Term>Levonordefrin</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Adrenergic Agent</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Adjuvant/Adrenergic Agent/Levonordefrin</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Adjuvant</BroaderTerm>
<BroaderTerm>Levonordefrin</BroaderTerm>
<BroaderTerm>Adrenergic Agent</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>(-)-alpha-(1-Aminoethyl)-3,4-dihydroxybenzyl Alcohol</Synonym>
<Synonym>1,2-Benzenediol, 4-(2-amino-1-hydroxypropyl)-,(R-(R*,S*))-</Synonym>
<Synonym>LEVONORDEFRIN</Synonym>
<Synonym>Levonordefrin</Synonym>
<Synonym>Neo-Cobefrin</Synonym>
<Description>The levoisomer of nordefrin, a synthetic catecholamine and norepinephrine derivative with sympathomimetic and antihypertensive effects. Levonordefrin's antihypertensive effect is exerted through activation of alpha 2-adrenergic receptors in the cardiovascular control center of the CNS thereby suppressing the sympathetic output from the brain and subsequently lowering blood pressure. Levonordefrin binds to and activates peripheral alpha 2- adrenergic receptors, thereby causing vasoconstriction.</Description>
<Source>NCI Thesaurus</Source>
</Record>
